Figure 4.
Proportion of the therapeutic window grouped by antiplatelet agent based on Caucasian criteria (85 < platelet reactivity unit [PRU] ≤ 208). HPR, high on-treatment platelet reactivity; LPR, low on-treatment platelet reactivity.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.